For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

You are here

Publications

Found 778 results
Author Title [ Type(Asc)] Year
Journal Article
R Malcolm K, Veazey RS, Geer L, Lowry D, Fetherston SM, Murphy DJ, Boyd P, Major I, Shattock RJ, Klasse PJohan et al..  2012.  Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaques.. Antimicrob Agents Chemother. 56(5):2251-8.
M Cappiello G, Sutterwala FS, Trinchieri G, Mosser DM, Ma X.  2001.  Suppression of Il-12 transcription in macrophages following Fc gamma receptor ligation.. J Immunol. 166(7):4498-506.
Leavenworth JW, Ma X, Mo Y-yuan, Pauza ME.  2009.  SUMO conjugation contributes to immune deviation in nonobese diabetic mice by suppressing c-Maf transactivation of IL-4.. J Immunol. 183(2):1110-9.
Small JL, O'Donoghue AJ, Boritsch EC, Tsodikov OV, Knudsen GM, Vandal O, Craik CS, Ehrt S.  2013.  Substrate specificity of MarP, a periplasmic protease required for resistance to acid and oxidative stress in Mycobacterium tuberculosis.. J Biol Chem. 288(18):12489-99.
Schoggins JW, Gall JGD, Falck-Pedersen E.  2003.  Subgroup B and F fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo.. J Virol. 77(2):1039-48.
Holloman WK, Rowe TC, Rusche JR.  1981.  Studies on nuclease alpha from Ustilago maydis.. J Biol Chem. 256(10):5087-94.
Holloman WK.  1973.  Studies on a nuclease from Ustilago maydis. II. Substrate specificity and mode of action of the enzyme.. J Biol Chem. 248(23):8114-9.
Holloman WK, Holliday R.  1973.  Studies on a nuclease from Ustilago maydis. I. Purification, properties, and implication in recombination of the enzyme.. J Biol Chem. 248(23):8107-13.
Liu F, Dawadi S, Maize KM, Dai R, Park SWoong, Schnappinger D, Finzel BC, Aldrich CC.  2017.  Structure-Based Optimization of Pyridoxal 5'-Phosphate-Dependent Transaminase Enzyme (BioA) Inhibitors that Target Biotin Biosynthesis in Mycobacterium tuberculosis.. J Med Chem. 60(13):5507-5520.
Liu J, Deng Y, Dey AK, Moore JP, Lu M.  2009.  Structure of the HIV-1 gp41 membrane-proximal ectodomain region in a putative prefusion conformation.. Biochemistry. 48(13):2915-23.
Rubin BP, Ferguson DO, Holloman WK.  1994.  Structure of REC2, a recombinational repair gene of Ustilago maydis, and its function in homologous recombination between plasmid and chromosomal sequences.. Mol Cell Biol. 14(9):6287-96.
Santos Rde Luna Al, Bai L, Singh PK, Murakami N, Fan H, Zhan W, Zhu Y, Jiang X, Zhang K, Assker JPierre et al..  2017.  Structure of human immunoproteasome with a reversible and noncompetitive inhibitor that selectively inhibits activated lymphocytes.. Nat Commun. 8(1):1692.
Autexier C, Lue NF.  2006.  The structure and function of telomerase reverse transcriptase.. Annu Rev Biochem. 75:493-517.
Yu EYoung, Zahid SS, Ganduri S, Sutherland JH, Hsu M, Holloman WK, Lue NF.  2020.  Structurally distinct telomere-binding proteins in Ustilago maydis execute non-overlapping functions in telomere replication, recombination, and protection.. Commun Biol. 3(1):777.
Mosior J, Bourland R, Soma S, Nathan C, Sacchettini J.  2019.  Structural insights into phosphopantetheinyl hydrolase PptH from Mycobacterium tuberculosis.. Protein Sci.
Biswas T, Small J, Vandal O, Odaira T, Deng H, Ehrt S, Tsodikov OV.  2010.  Structural insight into serine protease Rv3671c that Protects M. tuberculosis from oxidative and acidic stress.. Structure. 18(10):1353-63.
Orth P, Schnappinger D, Hillen W, Saenger W, Hinrichs W.  2000.  Structural basis of gene regulation by the tetracycline inducible Tet repressor-operator system.. Nat Struct Biol. 7(3):215-9.
Sun J, Yang Y, Wan K, Mao N, Yu T-Y, Lin Y-C, DeZwaan DC, Freeman BC, Lin J-J, Lue NF et al..  2011.  Structural bases of dimerization of yeast telomere protein Cdc13 and its interaction with the catalytic subunit of DNA polymerase α.. Cell Res. 21(2):258-74.
Kang YKenneth, Andjelic S, Binley JM, Crooks ET, Franti M, Iyer SPrasad N, Donovan GP, Dey AK, Zhu P, Roux KH et al..  2009.  Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1.. Vaccine. 27(37):5120-32.
W Horne S, Johnson LM, Ketas TJ, Klasse PJohan, Lu M, Moore JP, Gellman SH.  2009.  Structural and biological mimicry of protein surface recognition by alpha/beta-peptide foldamers.. Proc Natl Acad Sci U S A. 106(35):14751-6.
Shimosato T, Kimura T, Tohno M, Iliev ID, Katoh S, Ito Y, Kawai Y, Sasaki T, Saito T, Kitazawa H.  2006.  Strong immunostimulatory activity of AT-oligodeoxynucleotide requires a six-base loop with a self-stabilized 5'-C...G-3' stem structure.. Cell Microbiol. 8(3):485-95.
Iliev ID, Kitazawa H, Shimosato T, Katoh S, Morita H, He F, Hosoda M, Saito T.  2005.  Strong immunostimulation in murine immune cells by Lactobacillus rhamnosus GG DNA containing novel oligodeoxynucleotide pattern.. Cell Microbiol. 7(3):403-14.
Iliev ID, Underhill DM.  2013.  Striking a balance: fungal commensalism versus pathogenesis.. Curr Opin Microbiol. 16(3):366-73.
Frank M, Dzikowski R, Costantini D, Amulic B, Berdougo E, Deitsch K.  2006.  Strict pairing of var promoters and introns is required for var gene silencing in the malaria parasite Plasmodium falciparum.. J Biol Chem. 281(15):9942-52.
Vaubourgeix J, Lin G, Dhar N, Chenouard N, Jiang X, Botella H, Lupoli T, Mariani O, Yang G, Ouerfelli O et al..  2015.  Stressed mycobacteria use the chaperone ClpB to sequester irreversibly oxidized proteins asymmetrically within and between cells.. Cell Host Microbe. 17(2):178-90.